Contribution to clinical study
I have worked for the Ministry of the Attorney General in Toronto since my call to the Bar. In the fall of 2019, I became the Deputy Public Guardian and Trustee, Program Policy.
In 2016, I was diagnosed with a rare genetic disorder and in the spring of 2017, Parkinson’s disease. Earlier this year, I was honoured to be one of four patients involved in a Phase 1 clinical study in which MRI focused ultrasound was used to open the blood brain barrier around one side of the putamen, while a drug, Cerezyme, was administered. My hope is that this will help advance the treatment of PD.
— Susan Fullerton (BA’87, JD’90)